Throat Lozenges Market Size, Share, Growth Analysis, By Product type,(Medicated Throat Lozenges, and Non-Medicated Throat Lozenges.), By Flavor Variation (Menthol, Eucalyptus Oil), By Ingredient Type(Cherry, Mint) - Industry Forecast 2024-2031

Report ID: SQMIG35D2213 | Region: Global | Published Date: March, 2024
Pages: 206 | Tables: 93 | Figures: 76

Share your requirements to help us to customize the report.

I acknowledge that I have read the Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

License Type Top market research company in USA

File Type

Analyst Support

$5,300

BUY NOW GET FREE SAMPLE

FAQs

Throat Lozenges Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.62 billion in 2023 to USD 9.92 billion by 2031, growing at a CAGR of 24.52% in the forecast period (2024-2032).

The aggressive environment of the Throat Lozenges marketplace is characterized by means of the energetic participation of most important pharmaceutical and healthcare groups, in addition to area of interest gamers specializing in over-the-counter remedies. Key gamers interact in strategic initiatives, such as product innovation, mergers, acquisitions, and partnerships, to hold a competitive edge. Well-hooked up brands dominate the marketplace with their full-size product portfolios, leveraging their big distribution networks. However, the market also witnesses the access of smaller gamers supplying specific formulations, often emphasizing herbal or herbal substances. 'Reckitt Benckiser Group plc', 'GlaxoSmithKline plc', 'Mondelez International, Inc. (Halls)', 'Procter & Gamble Co. (Vicks)', 'Nestlé S.A.', 'Johnson & Johnson', 'Ricola AG', 'Bayer AG', 'Church & Dwight Co., Inc. (Ricola)', 'Pfizer Inc. (ChapStick)', 'Bionorica SE', 'Roxane Laboratories, Inc.', 'Wrigley Company', 'Mars, Incorporated (Fisherman's Friend)', 'Ernest Jackson & Company Ltd.', 'RemeGen Co., Ltd.', 'CF PharmTech, Inc.', 'Fertin Pharma A/S', 'Bach Remedy Ltd.', 'Plethico Pharmaceuticals Limited'

The recurrent prevalence of throat irritations, regularly associated with not unusual colds and respiration infections, serves as a primary driver. Consumers are looking for handy and effective answers for instant remedy, riding the demand for throat lozenges.

North America is anticipated to dominate the throat lozenges marketplace because of the region's excessive prevalence of breathing problems, inclusive of colds and flu. The call for throat lozenges is constantly excessive, riding market boom. The nicely hooked up healthcare infrastructure in North America ensures smooth accessibility to over-the-counter medicinal drugs, together with throat lozenges. This accessibility contributes to the dominance of the vicinity in the marketplace.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Throat Lozenges Market Size, Share, Growth Analysis, By Product type,(Medicated Throat Lozenges, and Non-Medicated Throat Lozenges.), By Flavor Variation (Menthol, Eucalyptus Oil), By Ingredient Type(Cherry, Mint) - Industry Forecast 2024-2031

Share your requirements to help us to customize the report.

Confidentiality

FAQs

What is the market size of Throat Lozenges Market?

Who are the key vendors in the Throat Lozenges Market?

What is the key driver of Throat Lozenges Market?

What is the key market trend for Throat Lozenges Market?

Which region accounted for the largest share in Throat Lozenges Market?

Related Reports

Feedback From Our Clients

$5,300